Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Examination of factors associated with use rates after transition from a universal to partial motorcycle helmet use law.

Russo BJ, Barrette TP, Morden J, Savolainen PT, Gates TJ.

Traffic Inj Prev. 2017 Jan 2;18(1):95-101. Epub 2016 Apr 13.

PMID:
27074388
2.

The landscape of long noncoding RNAs in the human transcriptome.

Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, Poliakov A, Cao X, Dhanasekaran SM, Wu YM, Robinson DR, Beer DG, Feng FY, Iyer HK, Chinnaiyan AM.

Nat Genet. 2015 Mar;47(3):199-208. doi: 10.1038/ng.3192. Epub 2015 Jan 19.

3.

Expressed pseudogenes in the transcriptional landscape of human cancers.

Kalyana-Sundaram S, Kumar-Sinha C, Shankar S, Robinson DR, Wu YM, Cao X, Asangani IA, Kothari V, Prensner JR, Lonigro RJ, Iyer MK, Barrette T, Shanmugam A, Dhanasekaran SM, Palanisamy N, Chinnaiyan AM.

Cell. 2012 Jun 22;149(7):1622-34. doi: 10.1016/j.cell.2012.04.041.

4.

Personalized oncology through integrative high-throughput sequencing: a pilot study.

Roychowdhury S, Iyer MK, Robinson DR, Lonigro RJ, Wu YM, Cao X, Kalyana-Sundaram S, Sam L, Balbin OA, Quist MJ, Barrette T, Everett J, Siddiqui J, Kunju LP, Navone N, Araujo JC, Troncoso P, Logothetis CJ, Innis JW, Smith DC, Lao CD, Kim SY, Roberts JS, Gruber SB, Pienta KJ, Talpaz M, Chinnaiyan AM.

Sci Transl Med. 2011 Nov 30;3(111):111ra121. doi: 10.1126/scitranslmed.3003161.

5.

Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing.

Pflueger D, Terry S, Sboner A, Habegger L, Esgueva R, Lin PC, Svensson MA, Kitabayashi N, Moss BJ, MacDonald TY, Cao X, Barrette T, Tewari AK, Chee MS, Chinnaiyan AM, Rickman DS, Demichelis F, Gerstein MB, Rubin MA.

Genome Res. 2011 Jan;21(1):56-67. doi: 10.1101/gr.110684.110. Epub 2010 Oct 29.

6.

An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.

Yu J, Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, Wang X, Wu L, Li J, Hu M, Gong Y, Cheng H, Laxman B, Vellaichamy A, Shankar S, Li Y, Dhanasekaran SM, Morey R, Barrette T, Lonigro RJ, Tomlins SA, Varambally S, Qin ZS, Chinnaiyan AM.

Cancer Cell. 2010 May 18;17(5):443-54. doi: 10.1016/j.ccr.2010.03.018.

7.

Chimeric transcript discovery by paired-end transcriptome sequencing.

Maher CA, Palanisamy N, Brenner JC, Cao X, Kalyana-Sundaram S, Luo S, Khrebtukova I, Barrette TR, Grasso C, Yu J, Lonigro RJ, Schroth G, Kumar-Sinha C, Chinnaiyan AM.

Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12353-8. doi: 10.1073/pnas.0904720106. Epub 2009 Jul 10.

8.

Transcriptome sequencing to detect gene fusions in cancer.

Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, Jing X, Sam L, Barrette T, Palanisamy N, Chinnaiyan AM.

Nature. 2009 Mar 5;458(7234):97-101. doi: 10.1038/nature07638. Epub 2009 Jan 11.

9.

Molecular concepts analysis links tumors, pathways, mechanisms, and drugs.

Rhodes DR, Kalyana-Sundaram S, Tomlins SA, Mahavisno V, Kasper N, Varambally R, Barrette TR, Ghosh D, Varambally S, Chinnaiyan AM.

Neoplasia. 2007 May;9(5):443-54.

10.

Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles.

Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ, Kincead-Beal C, Kulkarni P, Varambally S, Ghosh D, Chinnaiyan AM.

Neoplasia. 2007 Feb;9(2):166-80.

11.

Probabilistic model of the human protein-protein interaction network.

Rhodes DR, Tomlins SA, Varambally S, Mahavisno V, Barrette T, Kalyana-Sundaram S, Ghosh D, Pandey A, Chinnaiyan AM.

Nat Biotechnol. 2005 Aug;23(8):951-9.

PMID:
16082366
12.

Mining for regulatory programs in the cancer transcriptome.

Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Barrette TR, Ghosh D, Chinnaiyan AM.

Nat Genet. 2005 Jun;37(6):579-83.

PMID:
15920519
13.

Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression.

Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM.

Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9309-14. Epub 2004 Jun 7.

14.

ONCOMINE: a cancer microarray database and integrated data-mining platform.

Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM.

Neoplasia. 2004 Jan-Feb;6(1):1-6.

15.

C5a-induced gene expression in human umbilical vein endothelial cells.

Albrecht EA, Chinnaiyan AM, Varambally S, Kumar-Sinha C, Barrette TR, Sarma JV, Ward PA.

Am J Pathol. 2004 Mar;164(3):849-59.

16.

The polycomb group protein EZH2 is involved in progression of prostate cancer.

Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, Chinnaiyan AM.

Nature. 2002 Oct 10;419(6907):624-9.

17.

alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation.

Kuefer R, Varambally S, Zhou M, Lucas PC, Loeffler M, Wolter H, Mattfeldt T, Hautmann RE, Gschwend JE, Barrette TR, Dunn RL, Chinnaiyan AM, Rubin MA.

Am J Pathol. 2002 Sep;161(3):841-8.

18.

Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer.

Rhodes DR, Barrette TR, Rubin MA, Ghosh D, Chinnaiyan AM.

Cancer Res. 2002 Aug 1;62(15):4427-33.

19.

Cloning, characterization, and embryonic expression analysis of the Drosophila melanogaster gene encoding insulin/relaxin-like peptide.

Nasonkin IO, Alikasifoglu A, Barrette T, Cheng MM, Thomas PM, Nikitin AG.

Biochem Biophys Res Commun. 2002 Jul 12;295(2):312-8.

PMID:
12150949
20.

alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.

Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, Pienta KJ, Ghosh D, Chinnaiyan AM.

JAMA. 2002 Apr 3;287(13):1662-70.

PMID:
11926890
21.

Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins.

Sreekumar A, Nyati MK, Varambally S, Barrette TR, Ghosh D, Lawrence TS, Chinnaiyan AM.

Cancer Res. 2001 Oct 15;61(20):7585-93.

22.

Molecular signatures of sepsis: multiorgan gene expression profiles of systemic inflammation.

Chinnaiyan AM, Huber-Lang M, Kumar-Sinha C, Barrette TR, Shankar-Sinha S, Sarma VJ, Padgaonkar VA, Ward PA.

Am J Pathol. 2001 Oct;159(4):1199-209.

23.

Delineation of prognostic biomarkers in prostate cancer.

Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM.

Nature. 2001 Aug 23;412(6849):822-6.

24.

Ultrasonographic detection of testicular ischemia in a canine model using phospholipid coated microbubbles (MRX-115).

Metzger-Rose C, Krupinski EA, Wright WH, Baker MR, McCreery TP, Barrette TR, Unger EC.

J Ultrasound Med. 1997 May;16(5):317-24; quiz 325-6.

PMID:
9315169
25.

Evaluation of a low-density gastrointestinal contrast agent: effect on computed tomography angiography.

Alexander D, Krupinski E, Wright W, Barrette T, McCreery T, Unger E.

Acad Radiol. 1996 Aug;3 Suppl 2:S432-4. No abstract available.

PMID:
8796622
26.

Effect of phospholipid-coated microbubbles (MRX-115) on the detection of testicular ischemia in dogs.

Metzger-Rose C, Wright WH, Baker MR, Krupinski EA, McCreery TP, Barrette TR, Unger EC.

Acad Radiol. 1996 Aug;3 Suppl 2:S315-6. No abstract available.

PMID:
8796590
27.

Microbubbles as novel pressure-sensitive MR contrast agents.

Alexander AL, McCreery TT, Barrette TR, Gmitro AF, Unger EC.

Magn Reson Med. 1996 Jun;35(6):801-6.

PMID:
8744005
28.

Magnetic resonance guidance of percutaneous ethanol injection in liver.

Alexander AL, Barrette TR, Unger EC.

Acad Radiol. 1996 Jan;3(1):18-25.

PMID:
8796635
29.
30.

Hydraulic conductivity of basement membrane with computed values for fiber radius and void volume ratio.

Katz MA, Barrette T, Krasovich M.

Am J Physiol. 1992 Nov;263(5 Pt 2):H1417-21.

PMID:
1443196

Supplemental Content

Loading ...
Support Center